Concepedia

Michael T. Withnall

MT

6

Publications

147

Citations

6

H-Index

1972

Active since

Affiliations

University of Manchester(Current)

Michael T. Withnall is an author at University of Manchester specializing in medicine, cellular biochemistry, and molecular pharmacology.

Top concepts

MedicineCellular BiochemistryBiochemistryNatural SciencesMolecular PharmacologyImmunologyInflammationPharmacologyImmunotherapyCell Signaling

Publications per year

1972–1999

6

Publications

6

Calcium regulation of phospholipase A2 is independent of calmodulin

Michael T. Withnall, Thomas J. Brown, Baljeet K. Diocee · Biochemical and Biophysical Research Communications · 1984 · 45 citations

Molecular Pharmacology, Protein Function, Signal Transduction +11

Evidence that cyclic AMP phosphodiesterase inhibitors suppress interleukin‐2 release from murine splenocytes by interacting with a ‘low‐affinity’ phosphodiesterase 4 conformer

John E. Souness, Clare Houghton, Nughat Sardar et al. · British Journal of Pharmacology · 1997 · 34 citations · Full text

Immunotoxicology, Immunology, Immunologic Mechanism +18

Characterisation of cytosolic phospholipase A2 as mediator of the enhanced arachidonic acid release from dimethyl sulphoxide differentiated U937 cells

Michael T. Withnall, A. M. Pennington, David Wiseman · Biochemical Pharmacology · 1995 · 21 citations

U937 Cells, Oxysterol, Biochemistry +11

Suppression of anti-CD3-induced interleukin-4 and interleukin-5 release from splenocytes of mesocestoides corti-infected BALB/c mice by phosphodiesterase 4 inhibitors

John E. Souness, Clare Houghton, Nughat Sardar et al. · Biochemical Pharmacology · 1999 · 18 citations

Inflammation, Interleukin-5 Release, Autoimmune Disease +11

Pancreatic phospholipase A2 is not regulated by calmodulin

Michael T. Withnall, Thomas J. Brown · Biochemical and Biophysical Research Communications · 1982 · 16 citations

Molecular Pharmacology, Pancreatic Phospholipase A2, Signal Transduction +7

Rows per page

1–5 of 6